| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.00082 | 1 |